Theravance Poster to Show Phase 3 ATTAIN Trial Results on Pneumonia at ATS 2016
News, Pneumonia
Theravance Biopharma, Inc. recently announced in a press release the presentation of new data on VIBATIV® (telavancin), the company’s FDA-approved antibiotic, at the American Thoracic Society (ATS) 2016 International Conference, May 13-18 in San Francisco. The ... Read more